HomeINCY • NASDAQ
add
Incyte Corp
$70.81
Makalipas ang Oras ng Trabaho:(0.67%)+0.48
$71.29
Sarado: Hun 26, 7:29:55 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$67.55
Sakop ng araw
$69.84 - $71.50
Sakop ng taon
$53.56 - $83.94
Market cap
13.71B USD
Average na Volume
1.91M
P/E ratio
255.81
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.05B | 19.53% |
Gastos sa pagpapatakbo | 361.67M | 7.54% |
Net na kita | 158.20M | -6.69% |
Net profit margin | 15.03 | -21.92% |
Kita sa bawat share | 1.16 | 81.25% |
EBITDA | 239.82M | 110.11% |
Aktuwal na % ng binabayarang buwis | 32.45% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.41B | -37.45% |
Kabuuang asset | 5.75B | -19.43% |
Kabuuang sagutin | 2.08B | 19.55% |
Kabuuang equity | 3.67B | — |
Natitirang share | 193.57M | — |
Presyo para makapag-book | 3.57 | — |
Return on assets | 9.71% | — |
Return on capital | 15.06% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 158.20M | -6.69% |
Cash mula sa mga operasyon | 266.07M | 21.60% |
Cash mula sa pag-invest | 1.10M | 101.50% |
Cash mula sa financing | -12.68M | -2.12% |
Net change in cash | 253.94M | 91.49% |
Malayang cash flow | 275.84M | -0.51% |
Tungkol
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Itinatag
1991
Headquarters
Website
Mga Empleyado
2,617
